NorthRock Partners’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
SCP
NAMI
BIP
ETC
NorthRock Partners's ABEV Position: Q2 2026 in Review
NorthRock Partners reduced its Ambev (ABEV) stake by 7.2% in Q2 2026, selling an estimated $3.09K and leaving 12,771 shares worth $40.1K. The position accounts for ﹤0.01% of the portfolio, ranked #672.
NorthRock Partners first reported a position in ABEV in Q3 2025 and has held it in 4 quarters since. The position peaked at $40.2K in Q1 2026. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.
- NorthRock Partners held 12,771 shares of Ambev worth $40.1K as of Q2 2026.
- NorthRock Partners sold 989 Ambev shares in Q2 2026, an estimated $3.09K.
- Ambev made up ﹤0.01% of NorthRock Partners's portfolio in Q2 2026, its #672 holding.
- NorthRock Partners first reported a position in Ambev in Q3 2025 and has held it in 4 quarters since.
- NorthRock Partners's Ambev position peaked at $40.2K in Q1 2026.
- 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.
Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.